Transactions and pricing
On April 1, 2026, Oklo Inc. reported insider sales by CEO Jacob DeWitte and his spouse, Caroline Cochran, involving Class A common stock listed on NASDAQ under the ticker OKLO. The pair sold shares in multiple lots at prices ranging from $48.41 to $51.20 per share. The aggregate proceeds from the combined transactions amounted to $10,069,852.
Details of DeWitte’s sales
Jacob DeWitte sold 13,473 shares directly at $48.41 per share for $652,298.13 and an additional 10,516 shares at $49.58 for $521,381.28. He also disposed of 9,068 shares at $50.93, totaling $461,859.24, and 26,943 shares at $51.20, generating $1,379,481.60. A further block of 40,000 shares was sold at $50.50, yielding $2,020,000. The filings separately note that sales attributed to a Jacob DeWitte GRAT totaled $4,034,020.25.
Details of Cochran’s sales
Caroline Cochran sold an identical sequence of lots: 13,473 shares at $48.41 for $652,298.13; 10,516 shares at $49.58 for $521,381.28; 9,068 shares at $50.93 for $461,859.24; and 26,943 shares at $51.20 for $1,379,481.60. She also sold 40,000 shares at $50.50, amounting to $2,020,000. The filings indicate sales executed by a Caroline Cochran GRAT totaled $5,035,831.25.
Plan governing the trades and post-sale ownership
Oklo’s filings state these transactions were carried out under a pre-arranged Rule 10b5-1 trading plan that was adopted on March 31, 2025. Following the April 1 sales, Jacob DeWitte is reported to directly own 704,566 shares of Oklo Inc.
Market context and valuation commentary
Although the company’s stock has declined roughly 62 percent over the past six months, it still shows a year-to-date performance of about a 120 percent gain compared with the same period last year. According to InvestingPro analysis cited in the filings, Oklo’s shares currently appear overvalued relative to the service’s Fair Value estimate. The research notes Oklo’s market valuation at $8.35 billion and that the company remains unprofitable, with analysts not expecting the business to reach profitability in the current year.
Corporate developments
Oklo recently expanded a strategic partnership with Swedish nuclear technology firm Blykalla AB. Under the agreement, Blykalla plans to commit substantial capital and engineering resources to U.S. efforts to commercialize fast reactors, with potential investments noted in a range between $100 million and $200 million and the involvement of 30 to 40 engineers, subject to final approvals. Separately, Jacob DeWitte has been named to the President's Council of Advisors on Science and Technology, joining other senior technology and business figures.
Analyst moves and sector commentary
Analyst activity disclosed in the filings includes UBS lowering its price target on Oklo to $60 from $95 while maintaining a Neutral rating, citing execution risks and cost concerns. Craig-Hallum cut its price target to $71 from $87, pointing to capital requirements and continuing regulatory work. A Bernstein report referenced in the filings highlights the potential role of small modular reactors, such as those Oklo is developing, to supply continuous carbon-free power that could support AI deployments and hyperscaler demand.
Implications
The documented insider sales were executed within the constraints of a Rule 10b5-1 plan adopted last year and included transactions routed through GRAT vehicles. The filings provide exact lot-level pricing and confirm DeWitte’s remaining direct stake in the company. At the same time, third-party analysis contained in the filings flags valuation questions and notes Oklo’s unprofitable position, even as the company pursues partnerships and advisory appointments intended to advance its commercialization efforts.
Key facts
- Date of transactions: April 1, 2026
- Trading plan adoption date: March 31, 2025 (Rule 10b5-1)
- Total proceeds from combined sales: $10,069,852
- Post-transaction direct ownership for Jacob DeWitte: 704,566 shares
- Company valuation cited by InvestingPro: $8.35 billion